Data Bridge Market Research analyses that the South East Asia ready to drink/high strength premixes market, which was USD 8.61 billion in 2023, is expected to reach USD 11.96 billion by 2031, at a CAGR of 4.2% during the forecast period 2024 to 2031.
Read MoreThe Middle East molecular point of care testing (using NAAT) market size was valued at USD 274.00 million in 2024 and is expected to reach USD 484.16 million by 2032, at a CAGR of 7.4% during the forecast period
Read MoreThe Africa molecular point of care testing (using NAAT) market size was valued at USD 345.45 million in 2024 and is expected to reach USD 542.33 million by 2032, at a CAGR of 5.8% during the forecast period
Read MoreThe Europe molecular point of care testing (using NAAT) market size was valued at USD 2.16 billion in 2024 and is expected to reach USD 4.91 billion by 2032, at a CAGR of 10.8% during the forecast period
Read MoreThe global embolization particle market size was valued at USD 2.40 billion in 2024 and is projected to reach USD 5.67 billion by 2032, with a CAGR of 11.32% during the forecast period of 2025 to 2032.
Read More